Neuropeptides

Papers
(The TQCC of Neuropeptides is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Intravenous administration of xenin-25 accelerates cyclic ruminal contractions in healthy conscious sheep51
Editorial Board34
Restraint stress potentiates sensitivity to the antinociceptive effect of morphine through orexin receptors in the ventral tegmental area27
Interaction of glucocorticoids and interleukins in the control of hypothalamic neurohypophysial system output in salt loaded male rats24
Modulation of temporoammonic-CA1 synapses by neuropeptide Y is through Y1 receptors in mice23
Amylin regulates testosterone levels via steroidogenesis-related enzymes in the central nervous system of male mice23
Editorial Board22
Neuropeptide FF prevented histamine- or chloroquine-induced acute itch behavior through non-NPFF receptors mechanism in male mice22
Enteroendocrine cell-derived peptide YY signalling is stimulated by pinolenic acid or Intralipid and involves coactivation of fatty acid receptors FFA1, FFA4 and GPR11922
The use of intranasal oxytocin in the treatment of eating disorders21
Salivary oxytocin responses in mothers and full-term newborns in early skin-to-skin contact for the first 2 hours after birth: Effects of synthetic oxytocin administration and epidural analgesia in la20
Neuropeptide Y and receptors are associated with the pyroptosis of nucleus pulposus in aging and degenerative intervertebral discs of rats20
Transcranial pulsed current stimulation alleviates neuronal pyroptosis and neurological dysfunction following traumatic brain injury via the orexin-A/NLRP3 pathway17
Netrin-3 enhances recovery and reduces inflammation following spinal cord injury via suppressing NLRP1 inflammasome activation16
4-hydroxyisoleucine mediated IGF-1/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental rats15
Profile of cocaine and amphetamine regulated transcript peptide (CARTp) and Corticotropin-releasing factor (CRF) in the brain of Euphlyctis cyanophlyctis during puddle desiccation15
Fat mass and obesity-associated protein regulates RNA methylation associated with spatial cognitive dysfunction after chronic cerebral hypoperfusion15
Chemogenetic activation of arcuate nucleus NPY and NPY/AgRP neurons increases feeding behaviour in mice15
Physiologically relevant lactate accumulation from exercise or peripheral injection does not alter central or peripheral appetite signaling in mice14
Active immunotherapy against pathogenic Cis pT231-tau suppresses neurodegeneration in traumatic brain injury mouse models14
Editorial Board13
Role of endothelin in the pathophysiology of migraine: A new view on an old player13
The effects of corticotropin-releasing factor (CRF) and urocortins on the serotonin (hydroxytryptamine, 5HT) released from the raphe nuclei (RN)13
Antioxidant PRDX3 gene therapy protects brain cells and prevents neurodegeneration in an animal model of Parkinson's disease13
Irisin alleviates anxiety and deficits in fear extinction in PTSD within SPS mouse model12
Substance P mitigates lipopolysaccharide induced cognitive impairment in rats in a dose dependent manner12
Effects of voluntary, and forced exercises on neurotrophic factors and cognitive function in animal models of Parkinson's disease12
Perioperative changes of serum orphanin in diabetic patients and its relationship with sympathetic nervous system11
Efficacy of Ninjin'yoeito in treating severe coronavirus disease 2019 in patients in an intensive care unit11
The role of NPY signaling pathway in diagnosis, prognosis and treatment of stroke11
Neonatal oxytocin treatment alters levels of precursor and mature BDNF forms and modifies the expression of neuronal markers in the male rat hippocampus10
Investigating the potential of GalR2 as a drug target for neuropathic pain10
Long-term administration of ninjin'yoeito to treat frailty in older adults: A case series10
FGF-18 alleviates memory impairments and neuropathological changes in a rat model of Alzheimer's disease10
Neuropeptide regulation by herbal medicine9
The restraint stress-induced antinociceptive effects decreased by antagonism of both orexin receptors within the CA1 region of the hippocampus9
Immunohistochemical determination of the excitatory and inhibitory axonal endings contacting NUCB2/nesfatin-1 neurons9
Analgecine protects against cerebral ischemia-reperfusion through apoptosis inhibition and anti-neuroinflammation in rats9
The phenotypic changes of Schwann cells promote the functional repair of nerve injury8
Bromelain decreases oxidative stress and Neuroinflammation and improves motor function in adult male rats with cerebellar Ataxia induced by 3-acetylpyridine8
Disuse muscle atrophy-improving effect of ninjin'yoeito in a mouse model8
Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach8
PQK7: A novel peptide inhibitor targeting alpha-synuclein fibrillogenesis in Parkinson's disease8
Interferon beta attenuates recognition memory impairment and improves brain glucose uptake in a rat model of Alzheimer's disease: Involvement of mitochondrial biogenesis and PI3K pathway8
Dynorphin B induces mitochondrial fragmentation in NSCLC through the PKD/DRP-1 signaling pathway8
WITHDRAWN: CircBUB1 activates the PI3K/AKT signaling pathway to promote the migration and invasion of glioblastoma cells7
Localization of neuropeptide receptor NPY4R in rat retina7
Thyrotropin-releasing hormone induces Ca2+ increase in a subset of vagal nodose ganglion neurons7
Sex-dimorphic hindbrain lactate regulation of ventromedial hypothalamic nucleus glucoregulatory neuron 5’-AMP-activated protein kinase activity and transmitter marker protein expression7
The stress-induced antinociceptive responses to the persistent inflammatory pain involve the orexin receptors in the nucleus accumbens7
CDNF overexpression prevents motor-cognitive dysfunction by intrastriatal CPP-based delivery system in a Parkinson's disease animal model7
Editorial Board6
Molecular mechanisms of GDNF/GFRA1/RET and PI3K/AKT/ERK signaling interplay in neuroprotection: Therapeutic strategies for treating neurological disorders6
Neuropeptide Y Y2 receptors in acute and chronic pain and itch6
GnRH protective effects against long-term potentiation impairment induced by AANAT-siRNA6
Editorial Board6
The protective effects of orexin B in neuropathic pain by suppressing inflammatory response6
Mechanistic role of proteins and peptides in Management of Neurodegenerative Disorders6
Editorial Board6
Neuropeptides or their receptors in pathogenesis of lung diseases and therapeutic potentials6
A Na+ channel receptor of FMRFamide in the cephalopod Sepiella japonica: Identification, characterisation, and expression profiling during different stages of gonadal development6
Editorial Board6
Research progress on the protection and mechanism of active peptides in Alzheimer's disease and Parkinson's disease6
Cross talk about the role of Neuropeptide Y in CNS disorders and diseases6
The role of cholecystokinin and peptide YY in feed intake in Atlantic halibut (Hippoglossus hippoglossus) larvae6
0.090029954910278